Cargando…

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

Given the continued interest in defining the optimal management of individuals with type 2 diabetes, the Editor of Diabetes Care convened a working party of diabetes specialists to examine this topic in the context of insulin therapy. This was prompted by recent new evidence on the use of insulin in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Home, Philip, Riddle, Matthew, Cefalu, William T., Bailey, Clifford J., Bretzel, Reinhard G., del Prato, Stefano, Leroith, Derek, Schernthaner, Guntram, van Gaal, Luc, Raz, Itamar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Perspectives in Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131884/ https://www.ncbi.nlm.nih.gov/pubmed/24855154 http://dx.doi.org/10.2337/dc13-2743

Ejemplares similares

Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508
por: Home, Philip, et al.
Publicado: (2014)

Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management: Reflections From a Diabetes Care Editors’ Expert Forum
por: Cefalu, William T., et al.
Publicado: (2014)

Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections from a Diabetes Care Editors’ Expert Forum
por: Raz, Itamar, et al.
Publicado: (2013)

Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors’ Expert Forum
por: Cefalu, William T., et al.
Publicado: (2015)

Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?
por: Giaccari, Andrea, et al.
Publicado: (2021)

Insulin’s Role in Diabetes Management: After 90 Years, Still Considered the Essential “Black Dress”
por: Cefalu, William T., et al.
Publicado: (2015)

Introduction to the 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
por: Raz, Itamar, et al.
Publicado: (2016)

Clinical Assessment of Individualized Glycemic Goals in Patients With Type 2 Diabetes: Formulation of an Algorithm Based on a Survey Among Leading Worldwide Diabetologists
por: Cahn, Avivit, et al.
Publicado: (2015)

COVID-19, Hyperglycemia, and New-Onset Diabetes
por: Khunti, Kamlesh, et al.
Publicado: (2021)

Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Red and Processed Meats and Health Risks: How Strong Is the Evidence?
por: Qian, Frank, et al.
Publicado: (2020)

Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D)
por: Schernthaner, Guntram, et al.
Publicado: (2017)

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
por: Bergenstal, Richard M., et al.
Publicado: (2018)

Lost opportunities to prevent early onset type 2 diabetes mellitus after a pregnancy complicated by gestational diabetes
por: Bernstein, Judith A, et al.
Publicado: (2016)

Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes
por: Schernthaner, Guntram, et al.
Publicado: (2017)

Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes
por: Feher, Michael D, et al.
Publicado: (2016)

Global Call for Free Academic Movement for International Dialogue
por: Raz, Itamar, et al.
Publicado: (2012)

Getting to the “Heart” of the Matter on Diabetic Cardiovascular Disease: “Thanks for the Memory”
por: Cefalu, William T., et al.
Publicado: (2016)

Introduction to the Third World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): Outcome studies versus clinical experience in the treatment of diabetes
por: Raz, Itamar, et al.
Publicado: (2011)

Introduction to the 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
por: Del Prato, Stefano, et al.
Publicado: (2013)

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum
por: Cefalu, William T., et al.
Publicado: (2018)

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
por: Rosenstock, J., et al.
Publicado: (2008)

Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes?
por: Schernthaner, Guntram
Publicado: (2021)

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
por: Schernthaner, Guntram
Publicado: (2021)

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum
por: Cefalu, William T., et al.
Publicado: (2016)

Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies
por: Schernthaner, Guntram, et al.
Publicado: (2018)

NIDDK International Conference Report on Diabetes and Depression: Current Understanding and Future Directions
por: Holt, Richard I.G., et al.
Publicado: (2014)

Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action
por: Draznin, Boris, et al.
Publicado: (2013)

Diabetic muscle infarction: a systematic review
por: Horton, William B, et al.
Publicado: (2015)

Implementation of routine foot check in patients with diabetes on hemodialysis: associations with outcomes
por: Marn Pernat, Andreja, et al.
Publicado: (2016)

The National Diabetes Education Program at 20 Years: Lessons Learned and Plans for the Future
por: Siminerio, Linda M., et al.
Publicado: (2018)

Declines in the Incidence of Diabetes in the U.S.—Real Progress or Artifact?
por: Selvin, Elizabeth, et al.
Publicado: (2017)

Discovering successful strategies for diabetic self-management: a qualitative comparative study
por: Weller, Susan C, et al.
Publicado: (2017)

Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database study
por: Bonafede, Machaon, et al.
Publicado: (2016)

Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden
por: Moström, Peter, et al.
Publicado: (2017)

Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye?
por: Ferrannini, Ele, et al.
Publicado: (2021)

The Evolution of Hemoglobin A(1c) Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence
por: Redondo, Maria J., et al.
Publicado: (2021)

Adult-Onset Type 1 Diabetes: Current Understanding and Challenges
por: Leslie, R. David, et al.
Publicado: (2021)

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
por: Anderson, Randy L., et al.
Publicado: (2022)

Cystic Fibrosis–Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes
por: Putman, Melissa S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9bp5eu8nk4fu2ml5gkvcct7a2d